World Orphan Drug Congress USA
May 23 - 25, 2023 | Washington, D.C., USA
We are pleased to announce that we will be joining the World Orphan Drug Congress USA. This signature event brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers.
At Alira Health, we’re committed to rare disease awareness and support. Our goal is to bring the patient voice into healthcare development, and this includes our involvement with associations like EURORIS Rare Diseases Europe, which, among other efforts raises awareness and helps patients to get involved in finding solutions.
Meet Our Delegates
Kenny CarberryVP, Business Development, North America, Research & Clinical Development
Discover our Rare Disease Materials
- The Role of Patients in the Development of Rare Disease Solutions
- How to Integrate the Patient Voice in Rare Disease Clinical Trials
- Impact of the Orphan Drug Act on Rare Disease Patients and the Pharmaceutical Industry
- Regulatory Strategy for Registering Rare Disease Products in the EU: What You Need to Know